ANN WOOD: Open Payments
NPI 1992034284 · DECATUR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,537 in 72 payments from 33 companies in 2025. Trend: 2023 $1,759 · 2024 $1,654 · 2025 $1,537
Food & beverage: $1,537
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $197 |
| Novartis Pharmaceuticals Corporation | 9 | $155 |
| AstraZeneca Pharmaceuticals LP | 5 | $111 |
| Janssen Biotech, Inc. | 5 | $110 |
| E.R. Squibb & Sons, L.L.C. | 5 | $85 |
| Celgene Corporation | 3 | $62 |
| BeOne Medicines USA, Inc. | 3 | $61 |
| Alexion Pharmaceuticals, Inc. | 2 | $50 |
| Incyte Corporation | 2 | $47 |
| ABBVIE INC. | 3 | $47 |
Products named: KEYTRUDA, KISQALI, REBLOZYL, OPDIVO, EPKINLY, TEVIMBRA, TALVEY, ULTOMIRIS.
Industry payments across AL — which companies pay providers there.
